US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gene Therapy Market Research Reports & Industry Analysis

RSS Feeds

Gene Therapy Industry Research & Market Reports

Gene Therapy in Oncology Drug Pipeline Update 2014
10/27/2014 | published by: BioSeeker Group AB
... the accumulated number of ceased drugs over the last years amount to another 99 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of ...  |  read more...
USD 6,746
Are neurologists ready to embrace gene therapy? - Physician Views
6/11/2014 | published by: FirstWord
... Between the beginning of last year and early April 2014, however, 11 different companies specialising in gene therapy raised $618 million from venture capitalists and the public markets. Momentum for this approach has been driven ...  |  read more...
USD 645
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2
7/1/2014 | published by: MarketsandMarkets
... The report segments the cell culture market into two distinct market segments, namely, the cell culture equipment market and the cell culture media, sera, and reagents market. The segments of the cell culture equipment market ...  |  read more...
USD 4,650
Gene Therapy Partnering Terms and Agreements
5/1/2014 | published by: Current Partnering
... in gene therapypartnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Gene therapypartnering contract documents Top gene therapy deals by value The Gene Therapy Partnering Terms and Agreements report provides an understanding ...  |  read more...
USD 1,995
Virus-Like Particles (VLPs) Trends
1/1/2014 | published by: Global Industry Analysts
... the absence of viral genetic material. While lacking the DNA material, VLPs retain key immunological characteristics of viruses including particulate structures; repetitive surfaces; and capability to induce innate immunity by activating molecular-pattern pathogen-associated recognition receptors." ...  |  read more...
USD 950
Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) Market (2012 – 2017)
12/17/2012 | published by: MarketsandMarkets
... provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends. Global research and development Network, Innovation and Spin offs have been discussed. The ...  |  read more...
USD 4,650
The 2013 Report on Gene Therapy: World Market Segmentation by City
6/19/2013 | published by: Icon Group International, Inc.
... as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major ...  |  read more...
USD 795
The 2013-2018 Outlook for Gene Therapy in the United States
7/17/2013 | published by: Icon Group International, Inc.
... of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,300 cities in the United States. For each city in question, the percent share the city is of it’s state and of ...  |  read more...
USD 495
Single-Use Technologies for Biopharmaceuticals: Global Markets
1/1/2013 | published by: BCC Research
... for 2012, and projections of compound annual growth rates (CAGRs) through 2017 In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, ...  |  read more...
USD 6,650
The 2013-2018 Outlook for Gene Therapy in Greater China
5/19/2013 | published by: Icon Group International, Inc.
... Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to as “regions”). Latent demand (in millions of U.S. dollars), or potential industry ...  |  read more...
USD 495
Market For Gene Therapy and Antisense Drugs
8/1/1995 | published by: Kalorama Information
... $60 billion in 2005. This report from Kalorama Information examines the advantages and disadvantages of the various types of gene therapy and assesses which technologies and companies are likely to lead the market. Examines the ...  |  read more...
USD 1,625
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
12/1/2010 | published by: Kalorama Information
... other novel compounds targeting drugs to specific disease sites including gene therapy. Treatments for chronic conditions and growth in patient-administered drugs are factors leading to greater focus on ease-of-use and convenience. Advanced Drug Delivery Markets ...  |  read more...
USD 2,500
Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications
1/1/2005 | published by: Kalorama Information
... is an idea whose time has come. There are six types of nucleic acid-based therapeutics that have been proposed. Some have made it to market, others are still in development, and some have been put ...  |  read more...
USD 3,500
Gene Expression Profiling Markets
1/1/2008 | published by: Kalorama Information
... see revenues grow rapidly. However, different products and applications are increasingly being introduced, making the market more fragmented as well as unpredictable. In terms of application, too, the landscape is shifting. Although life-science research is ...  |  read more...
USD 995
Stem Cell Therapeutics Markets
2/1/2009 | published by: Kalorama Information
... to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ...  |  read more...
USD 995
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders
4/12/2012 | published by: GlobalData
... blood disorders such as beta-thalassemia and sickle cell anemia. An international team of researchers led by scientists at Weill-Cornell Medical College in New York City have designed a novel gene therapy strategy with potentially curative ...  |  read more...
USD 500
The 2009-2014 World Outlook for Gene Therapy
7/7/2009 | published by: Icon Group International, Inc.
... question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ...  |  read more...
USD 795
Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships
9/12/2011 | published by: Espicom Healthcare Intelligence
An examination of trends and advances in the three major drug delivery sectors Unique sales forecasts to 2020 for key products Critical analyses of 58 specialist developers driving the drug delivery market onwards  |  read more...
USD 2,265
Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications
6/12/2012 | published by: GBI Research
... CNS and Cardiovascular-Rich Pipeline Features Innovative Stem Cell and Gene Therapy Applications”, which provides insights into the global regenerative medicine therapeutics market. The report provides an in-depth analysis of regenerative medicine and the challenges in ...  |  read more...
USD 3,500
Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards
6/25/2012 | published by: GBI Research
... Failures, Close Regulatory Surveillance and High Compliance Standards”, provides in-depth analysis of the unmet needs, drivers and barriers that impact the global gene therapy market. The report analyzes technological aspects, advantages and disadvantages of various ...  |  read more...
USD 3,500
Gene Therapy
2/1/2012 | published by: Global Industry Analysts
... such as AnGes MG, Inc., BioSante Pharmaceuticals, GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based ...  |  read more...
USD 4,500
Cancer Bundle
8/1/2012 | published by: TriMark Publications
... Testing World Markets. Cancer Therapeutics Markets. Cancer Vaccines Markets. Companion Diagnostics in Personalized Medicine and Cancer Therapy. Cytology and HPV Testing World Markets. Game Changers in Breast Cancer Therapies. Molecular Diagnostics in Cancer Testing. Until ...  |  read more...
USD 26,010
Neuroprotective Products: World Market Prospects 2012-2022
5/10/2012 | published by: Visiongain
... projected sales at overall world market, therapeutic submarket and product level to 2022. The protection of nerve tissues is becoming more important. You can assess the potential for drug revenues there, as well as finding ...  |  read more...
USD 2,837
Drug Discovery and Preclinical Molecules by Therapy Area - Innovation Focuses on Stem Cell Therapies and Gene Therapies
2/10/2011 | published by: GBI Research
... Stem Cell Therapies and Gene Therapies”, provides an in-depth analysis of the unmet needs, drivers and barriers that affect the global Central Nervous System Disorders (CNS), Metabolic Disorders, Immunologic Disorders, Infection, Cardiovascular Disease and Oncology ...  |  read more...
USD 3,500